Example: Heart Attack

Search clinical trials for: Formoterol

Total 485 results

NCT01551888

Completed

Pharmacokinetic, Safety and Tolerability Study of Aclidinium/Formoterol Fixed Dose Combination and Formoterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
NCT00972140

Completed

Formoterol-HFA 3-month Study in Chronic Obstructive Pulmonary Disease (COPD) Patients

Conditions: Chronic Obstructive Pulmonary Disease
NCT03028701

Completed

Assessment of Bronchodilator Efficacy of Formoterol/Budesonide 12/400 mcg Via Discair in COPD

Conditions: Copd
NCT02345993

Unknown status

Extra-fine Formoterol/Beclomethasone in Asthmatic Crisis

Conditions: Asthma; Asthmatic Crisis
NCT03258749

Unknown status

Efficiency of Twice Daily Formoterol Versus Once Daily Tiotropium in Patients With GOLD A/B COPD

Conditions: Chronic Obstructive Pulmonary Disease
NCT00633776

Withdrawn

Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT)

Conditions: Chronic Obstructive Pulmonary Disease; COPD; Chronic Bronchitis; Emphysema
NCT03276078

Completed

Pharmacokinetics, Safety and Tolerability of Twice-Daily Aclidinium Bromide/Formoterol Fumarate Fixed Dose Combination in Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Conditions: Pulmonary Disease, Chronic Obstructive
NCT01488019

Completed

Study to Evaluate the Safety of Long-Term Use of Perforomist® (Formoterol Fumarate)

Conditions: COPD
NCT01377428

Withdrawn

Efficacy of Indacaterol 150 µg Versus Formoterol

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
NCT00914654

Unknown status

Concentrations of Formoterol in Blood and Urine

Conditions: Asthma
NCT01176747

Completed

Lung Deposition of the BDP/Formoterol Combination Administered Via the NEXT DPI in Healthy, Asthmatic and COPD Patients

Conditions: Pulmonary Disease, Chronic Obstructive; Asthma
NCT00685529

Completed

Study of Arformoterol Tartrate Inhalation Solution and Racemic Formoterol in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)

Conditions: COPD
NCT01194479

Completed

Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.

Conditions: Type 1 Diabetes
NCT01047553

Completed

Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) Patients

Conditions: Chronic Obstructive Pulmonary Disease
NCT04331470

Recruiting

Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19

Conditions: COVID-19
NCT03846570

Recruiting

Formoterol-beclomethasone in Patients With Bronchiectasis: a Randomized Controlled Trial

Conditions: Bronchiectasis
NCT02988869

Completed

Tiotropium/Formoterol Via Discair® vs Tiotropium Monotherapy or Tiotropium + Formoterol Free Combination Treatment

Conditions: COPD
NCT02268396

Completed

Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD

Conditions: COPD
NCT01786616

Completed

Polymorphism of beta2-adrenoceptor and Regular Use of Formoterol in Asthma

Conditions: Asthma
NCT04171180

Recruiting

The Efficacy of Budesonide/Formoterol in Cough Variant Asthma

Conditions: Cough Variant Asthma
NCT00929851

Completed

BDP/FF Versus Formoterol Fumarate (FF) in Patients With Severe COPD (Lung Function and Exacerbation Rate)

Conditions: Pulmonary Disease, Chronic Obstructive
NCT01676987

Completed

Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled Asthma

Conditions: Asthma
NCT03181880

Withdrawn

To Evaluate Effectiveness of Aclidinium Bromide/Formoterol Fumarate Dihydrate in Chronic Obstructive Pulmonary Disease

Conditions: Chronic Obstructive Pulmonary Disease
NCT04215848

Recruiting

As-needed Budesonide/Formoterol Turbuhaler in Stepping Down Period

Conditions: Asthma
NCT00643578

Completed

Dose-response of Inhaled Formoterol Using Methacholine Challenge as a Bioassay

Conditions: Asthma